Evidence map›Paper›PMID 41394614›Full record

ArticlebioRxiv : the preprint server for biology2025

Calibrated Variant Effect Prediction at the Residue Level Using Conditional Score Distributions.

Gal Passi, Sapir Amittai, Dina Schneidman-Duhovny

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gal PassiThe Rachel and Selim Benin School of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel.
Sapir AmittaiThe Rachel and Selim Benin School of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel.
Dina Schneidman-DuhovnyThe Rachel and Selim Benin School of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel.

Funding

ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
NIGMS NIH HHS R01 GM129325
6 · The paper itself

Abstract

Effective clinical use of variant effect prediction (VEP) requires models that are both accurate and well-calibrated. Calibration refers to a model's ability to produce meaningful and reliable probability estimates. Here, we propose a practical path toward robust VEP calibration by calibrating at the residue-level rather than using global or per-protein schemes. We identify variant subgroups that benefit from targeted calibration and show that, while VEPs appear well calibrated on average, they remain markedly miscalibrated within these subgroups. Leveraging these insights, we develop RaCoon (Residue-aware Calibration via Conditional distributions), implemented on ESM1b, which provides multicalibrated and interpretable predictions across diverse variant subgroups and significantly improves performance across multiple benchmarks. Targeted residue-level calibration not only improves overall calibration but, for most models, also yields gains in global AUROC. Specifically, RaCoon increases AUCROC from 0.912 to 0.924. Our calibration strategy, guided by model-specific feature distributions, is readily transferable to other VEPs.

Identifiers

PMID41394614
PMCPMC12697679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.